External validation of established risk adjustment models for procedural complications after percutaneous coronary intervention

Heart

Volumn 94, Issue 8, 2008, Pages 1012-1018

  Kunadian, B ^a   Dunning, J ^a   Das, R ^a   Roberts, A P ^a   Morley, R ^a   Turley, A J ^a   Twomey, D ^a   Hall, J A ^a   Wright, R A ^a   Sutton, A G C ^a   Muir, D F ^a   De Belder, M A ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; STROKE; UNITED KINGDOM;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; EMERGENCIES; ENGLAND; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK ADJUSTMENT; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 47849088223     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.129197     Document Type: Article

References (27)

1. Randolph AG, Guyatt GH, Carlet J. Understanding articles comparing outcomes among intensive care units to rate quality of care. Evidence Based Medicine in Critical Care Group. Crit Care Med 1998;26:773-81.
2. Topol EJ, Block PC, Holmes DR, et al. Readiness for the scorecard era in cardiovascular medicine. Am J Cardiol 1995;75:1170-3.
3. Hunt JP, Meyer AA. Predicting survival in the intensive care unit. Curr Probl Surg 1997;34:527-99.
4. Knaus WA, Wagner DP, Draper EA. The value of measuring severity of disease in clinical research on acutely ill patients. J Chronic Dis 1984;37:455-63.
5. Mendez-Tellez PA, Dorman T. Predicting patient outcomes, futility, and resource utilization in the intensive care unit: the role of severity scoring systems and general outcome prediction models. Mayo Clin Proc 2005;80:161-3.
6. Hannan EL, Racz M, Ryan TJ, et al. Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA 1997;277:892-8.
7. Holmes DR Jr, Berger PB, Garratt KN, et al. Application of the New York State PTCA mortality model in patients undergoing stent implantation. Circulation 2000;102:517-22.
8. Shaw RE, Anderson HV, Brindis RG, et al. Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. J Am Coll Cardiol 2002;39:1104-12.
9. Anderson HV, Shaw RE, Brindis RG, et al. Risk-adjusted mortality analysis of percutaneous coronary interventions by American College of Cardiology/American Heart Association guidelines recommendations. Am J Cardiol 2007;99:189-96.
10. O'Connor GT, Malenka DJ, Quinton H, et al. Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994-1996. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 1999;34:681-91.
11. Moscucci M, Kline-Rogers E, Share D, et al. Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions. Circulation 2001;104:263-8.
12. Qureshi MA, Safian RD, Grines CL, et al. Simplified scoring system for predicting mortality after percutaneous coronary intervention. J Am Coll Cardiol 2003;42:1890-5.
13. Ellis SG, Weintraub W, Holmes D, et al. Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation 1997;95:2479-84.
14. Singh M, Lennon RJ, Holmes DR Jr, et al. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol 2002;40:387-93.
15. Resnic FS, Ohno-Machado L, Selwyn A, et al. Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention. Am J Cardiol 2001;88:5-9.
16. Kimmel SE, Berlin JA, Strom BL, et al. Development and validation of simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice. The Registry Committee of the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1995;26:931-8.
17. Grayson AD, Moore RK, Jackson M, et al. Multivariate prediction of major adverse cardiac events after 9914 percutaneous coronary interventions in the north west of England. Heart 2006;92:658-63.
18. de Belder AJ, Jewitt DE, Wainwright RJ, et al. Development and validation of a Bayesian index for predicting major adverse cardiac events with percutaneous transluminal coronary angioplasty. Heart 2001;85:69-72.
19. Central Cardiac Audit Database. Coronary heart disease audit supported by the Central Cardiac Audit Database. Available from http://www ccad.org.uk (accessed 13 May 2008).
20. Singh M, Rihal CS, Selzer F, et al. Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry. J Am Coll Cardiol 2003;42:1722-8.
21. Hanley JA, Meengs WL. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Diagn Radiol 1982;143:29-36.
22. Stephan C, Wesseling S, Schink T, et al. Comparison of eight computer programs for receiver-operating characteristic analysis. Clin Chem 2003;49:433-9.
23. Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982;115:92-106.
24. Weintraub WS. Prediction scores after myocardial infarction: value, limitations, and future directions. Circulation 2002;106:2292-3.
25. Singh M, Rihal CS, Selzer F, et al. Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry. J Am Coll Cardiol 2003;42:1722-8.
26. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med 2000;19:453-73.
27. The TIMI-IIIA Investigators. Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Circulation 1993;87:38-52.